What is Nutex Health Inc share price today?

Nutex Health Inc (NUTX) share price today is {{live_price}}.

Can Indians buy Nutex Health Inc shares?

Yes, Indians can invest in the Nutex Health Inc (NUTX) from India. With INDmoney, you can buy Nutex Health Inc at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Nutex Health Inc at zero transaction cost.

How can I buy Nutex Health Inc shares from India?

It is very easy to buy Nutex Health Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Nutex Health Inc be purchased?

Yes, you can buy fractional shares of Nutex Health Inc with INDmoney app.

What are the documents required to start investing in Nutex Health Inc stocks?

To start investing in Nutex Health Inc, You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Nutex Health Inc

Today’s highest price of Nutex Health Inc (NUTX) is {{1_rba_end}}. Today’s lowest price of Nutex Health Inc (NUTX) is {{1_rba_st}}.

What is today's market capitalisation of Nutex Health Inc

Today's market capitalisation of Nutex Health Inc NUTX is 112.6M

What is the 52 Week High and Low Range of Nutex Health Inc

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Nutex Health Inc is down from its 52 Week High?

Nutex Health Inc (NUTX) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Nutex Health Inc is up from its 52 Week low?

Nutex Health Inc (NUTX) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Nutex Health Inc?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Nutex Health Inc

Dr. Thomas T. Vo M.B.A., M.D. is the current Chief Executive Officer (CEO) of Nutex Health Inc.

Home>
US Stocks>
Nutex Health Inc

Nutex Health Inc (NUTX)

$22.24

-0.06

(-0.27%)▲

Live

Performance

$21.87
$22.70
$22.24
1.66%
Downside
Day's Volatility :3.64%
Upside
2.01%
$4.16
$45.00
$22.24
81.29%
Downside
52 Weeks Volatility :90.76%
Upside
50.58%

Returns

Period	Nutex Health Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	218.8%	3.6%	0.0%
6 Months	223.47%	10.2%	0.0%
1 Year	-20.92%	19.6%	0.0%
3 Years	-99.63%	16.8%	-23.0%

Highlights

Market Capitalization	112.6M
Book Value	$12.58
Earnings Per Share (EPS)	-8.67
Wall Street Target Price	45.0

Profit Margin	-13.73%
Operating Margin TTM	15.73%

Return On Assets TTM	2.43%
Return On Equity TTM	-31.29%

Revenue TTM	275.9M
Revenue Per Share TTM	58.91
Quarterly Revenue Growth YOY	29.099999999999998%
Gross Profit TTM	36.3M
EBITDA	24.8M
Diluted Eps TTM	-8.67
Quarterly Earnings Growth YOY	0.0

EPS Estimate Current Year	-0.5
EPS Estimate Next Year	1.5
EPS Estimate Current Quarter	-0.29
EPS Estimate Next Quarter	-0.43

Analyst Recommendation

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Nutex Health Inc(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 102.34%

Current $22.24

Target $45.00

Company Financials

	FY18	Y/Y Change
Revenue	91.4K	↑ 70.32%
Net Income	-2.8M	↓ 583.5%
Net Profit Margin	-3.1K%	↓ 4164.94%

	FY19	Y/Y Change
Revenue	97.1M	↑ 106120.79%
Net Income	16.5M	↓ 685.72%
Net Profit Margin	16.98%	↑ 3096.93%

	FY20	Y/Y Change
Revenue	273.4M	↑ 181.71%
Net Income	106.0M	↑ 542.89%
Net Profit Margin	38.76%	↑ 21.78%

	FY21	Y/Y Change
Revenue	331.5M	↑ 21.25%
Net Income	132.6M	↑ 25.12%
Net Profit Margin	39.99%	↑ 1.23%

	FY22	Y/Y Change
Revenue	219.3M	↓ 33.85%
Net Income	-432.7M	↓ 426.37%
Net Profit Margin	-197.33%	↓ 237.32%

	FY23	Y/Y Change
Revenue	247.6M	↑ 12.93%
Net Income	-45.8M	↓ 89.42%
Net Profit Margin	-18.49%	↑ 178.84%

	Q1 FY23	Q/Q Change
Revenue	56.3M	↑ 4.85%
Net Income	-5.1M	↓ 51.71%
Net Profit Margin	-9.14%	↑ 10.7%

	Q2 FY23	Q/Q Change
Revenue	58.9M	↑ 4.61%
Net Income	-3.5M	↓ 32.41%
Net Profit Margin	-5.9%	↑ 3.24%

	Q3 FY23	Q/Q Change
Revenue	62.7M	↑ 6.45%
Net Income	-5.5M	↑ 59.31%
Net Profit Margin	-8.84%	↓ 2.94%

	Q4 FY23	Q/Q Change
Revenue	69.7M	↑ 11.07%
Net Income	-31.6M	↑ 470.47%
Net Profit Margin	-45.38%	↓ 36.54%

	Q1 FY24	Q/Q Change
Revenue	67.5M	↓ 3.18%
Net Income	-364.1K	↓ 98.85%
Net Profit Margin	-0.54%	↑ 44.84%

	Q2 FY24	Q/Q Change
Revenue	76.1M	↑ 12.79%
Net Income	-364.0K	↓ 0.01%
Net Profit Margin	-0.48%	↑ 0.06%

	FY18	Y/Y Change
Total Assets	2.6M	↓ 21.35%
Total Liabilities	1.4M	↑ 44.35%

	FY19	Y/Y Change
Total Assets	179.2M	↑ 6749.92%
Total Liabilities	128.4M	↑ 9166.97%

	FY20	Y/Y Change
Total Assets	308.6M	↑ 72.16%
Total Liabilities	161.2M	↑ 25.55%

	FY21	Y/Y Change
Total Assets	394.7M	↑ 27.9%
Total Liabilities	203.1M	↑ 25.98%

	FY22	Y/Y Change
Total Assets	431.8M	↑ 9.4%
Total Liabilities	311.4M	↑ 53.36%

	FY23	Y/Y Change
Total Assets	398.2M	↓ 7.76%
Total Liabilities	319.1M	↑ 2.48%

	Q1 FY23	Q/Q Change
Total Assets	430.1M	↓ 0.38%
Total Liabilities	320.6M	↑ 2.93%

	Q2 FY23	Q/Q Change
Total Assets	436.2M	↑ 1.43%
Total Liabilities	328.0M	↑ 2.32%

	Q3 FY23	Q/Q Change
Total Assets	479.6M	↑ 9.95%
Total Liabilities	374.7M	↑ 14.24%

	Q4 FY23	Q/Q Change
Total Assets	398.2M	↓ 16.97%
Total Liabilities	319.1M	↓ 14.83%

	Q1 FY24	Q/Q Change
Total Assets	404.3M	↑ 1.52%
Total Liabilities	324.3M	↑ 1.61%

	Q2 FY24	Q/Q Change
Total Assets	422.4M	↑ 4.48%
Total Liabilities	340.4M	↑ 4.97%

	FY19	Y/Y Change
Operating Cash Flow	12.1M	↓ 2625.71%
Investing Cash Flow	-31.2M	-
Financing Cash Flow	21.7M	↑ 2981.78%

	FY20	Y/Y Change
Operating Cash Flow	81.3M	↑ 570.24%
Investing Cash Flow	-61.2M	↑ 95.91%
Financing Cash Flow	-2.6M	↓ 111.8%

	FY21	Y/Y Change
Operating Cash Flow	173.4M	↑ 113.42%
Investing Cash Flow	-37.0M	↓ 39.57%
Financing Cash Flow	-125.9M	↑ 4811.68%

	FY22	Y/Y Change
Operating Cash Flow	50.6M	↓ 70.82%
Investing Cash Flow	-4.3M	↓ 88.27%
Financing Cash Flow	-48.1M	↓ 61.75%

	Q1 FY23	Q/Q Change
Operating Cash Flow	1.1M	↓ 76.65%
Investing Cash Flow	-5.4M	↓ 168.73%
Financing Cash Flow	2.9M	↓ 119.97%

	Q2 FY23	Q/Q Change
Operating Cash Flow	12.3K	↓ 98.83%
Investing Cash Flow	-3.1M	↓ 43.32%
Financing Cash Flow	3.0M	↑ 1.02%

Technicals Summary

Sell

Neutral

Buy

Nutex Health Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Nutex Health Inc	-0.56%	223.47%	-20.92%	-99.63%	-99.63%
Solventum Corp	5.08%	18.7%	6.63%	6.63%	6.63%
Tempus Ai	-10.87%	22.58%	22.58%	22.58%	22.58%
Veeva Systems Inc.	4.87%	11.18%	13.42%	-31.95%	52.57%
Ge Healthcare Technologies Inc.	0.51%	8.34%	42.74%	51.0%	51.0%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Nutex Health Inc	1.31	NA	NA	-0.5	-0.31	0.02	NA	12.58
Solventum Corp	NA	NA	NA	6.26	0.17	0.08	NA	NA
Tempus Ai	NA	NA	NA	-2.41	0.0	0.0	NA	0.64
Veeva Systems Inc.	57.72	57.72	1.25	4.76	0.13	0.06	NA	32.04
Ge Healthcare Technologies Inc.	26.25	26.25	2.37	4.25	0.21	0.06	0.0	17.08

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Nutex Health Inc	Buy	$112.6M	-99.63%	1.31	-13.73%
Solventum Corp	Hold	$10.8B	6.63%	NA	15.73%
Tempus Ai	NA	$7.9B	22.58%	NA	-121.04%
Veeva Systems Inc.	Buy	$35.1B	52.57%	57.72	23.91%
Ge Healthcare Technologies Inc.	Buy	$41.7B	51.0%	26.25	8.1%

Insights on Nutex Health Inc

Increasing Revenue
Revenue is up for the last 2 quarters, 67.45M → 76.08M (in $), with an average increase of 11.3% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -31.61M → -364.04K (in $), with an average increase of 4292.2% per quarter
Vs GEHC
In the last 1 year, Ge Healthcare Technologies Inc. has given 42.6% return, outperforming this stock by 68.2%